Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Gasior-Perczak, Danuta; Kowalik, Artur; Walczyk, Agnieszka; Siolek, Monika; Gruszczynski, Krzysztof; Palyga, Iwona; Mikina, Estera; Trybek, Tomasz; Kopczynski, Janusz; Mezyk, Ryszard; Gózdz, Stanislaw; Kowalska, Aldona

Coexisting Germline CHEK2 and Somatic BRAF^V600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course.

Gasior-Perczak, Danuta; Kowalik, Artur; Walczyk, Agnieszka; Siolek, Monika; Gruszczynski, Krzysztof; Palyga, Iwona; Mikina, Estera; Trybek, Tomasz; Kopczynski, Janusz; Mezyk, Ryszard; Gózdz, Stanislaw; Kowalska, Aldona.

Afiliação

Gasior-Perczak D; Endocrinology, Holycross Cancer Centre, S. Artwinskiego St. 3, 25-734 Kielce, Poland.
Kowalik A; Molecular Diagnostics, Holycross Cancer Centre, S. Artwinskiego Str. 3, 25-734 Kielce, Poland.
Walczyk A; Endocrinology, Holycross Cancer Centre, S. Artwinskiego St. 3, 25-734 Kielce, Poland.
Siolek M; Genetic Clinic, Holycross Cancer Centre, 25-734 Kielce, Poland.
Gruszczynski K; Molecular Diagnostics, Holycross Cancer Centre, S. Artwinskiego Str. 3, 25-734 Kielce, Poland.
Palyga I; Endocrinology, Holycross Cancer Centre, S. Artwinskiego St. 3, 25-734 Kielce, Poland.
Mikina E; Endocrinology, Holycross Cancer Centre, S. Artwinskiego St. 3, 25-734 Kielce, Poland.
Trybek T; Endocrinology, Holycross Cancer Centre, S. Artwinskiego St. 3, 25-734 Kielce, Poland.
Kopczynski J; Surgical Pathology, Holycross Cancer Centre, S. Artwinskiego Str. 3, 25-734 Kielce, Poland.
Mezyk R; Cancer Epidemiology, Holycross Cancer Center, 25-734 Kielce, Poland.
Gózdz S; The Faculty of Health Sciences, Jan Kochanowski University, IX Wieków Kielc Av. 19, 25-319 Kielce, Poland.
Kowalska A; Clinical Oncology, Holycross Cancer Centre, S. Artwinskiego Str. 3, 25-734 Kielce, Poland.

Cancers (Basel) ; 11(11)2019 Nov 07.

Article em En | MEDLINE | ID: mdl-31703344

Palavras-chave

BRAF mutation; CHEK2 mutation; papillary thyroid cancer; response to therapy; risk stratification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article